ctrl K

Price Alert

Xenon Pharmaceuticals Inc... (XENE)

NASDAQ: XENE · Real-Time Price · USD

38.23

0.27 (0.71%)

At close: Aug 15, 2025, 3:59 PM

38.23

0.00%

After-hours: Aug 15, 2025, 04:42 PM EDT

Xenon Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	142.71M	148.64M	57.24M	175.69M
Short-Term Investments	484.19M	489.44M	534.85M	376.09M
Long-Term Investments	127.5M	292.79M	128.68M	n/a
Other Long-Term Assets	7.5M	7.4M	7.75M	n/a
Receivables	1.47M	874K	986K	2.77M
Inventory	n/a	n/a	-986K	-2.77M
Other Current Assets	6.89M	6.01M	7.22M	n/a
Total Current Assets	635.26M	644.96M	600.3M	559.02M
Property-Plant & Equipment	18.22M	18.85M	16.91M	12.52M
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	162.88M	319.84M	153.85M	12.99M
Total Assets	798.14M	964.8M	754.15M	572.01M
Account Payables	5.07M	8.6M	8.49M	3.82M
Deferred Revenue	n/a	n/a	n/a	9.29M
Short-Term Debt	n/a	n/a	n/a	n/a
Other Current Liabilities	11.3M	347K	7.9M	3.95M
Total Current Liabilities	35.59M	27.27M	22.7M	14.32M
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	26.57M	n/a	n/a	n/a
Total Long-Term Liabilities	34.22M	9.6M	9.95M	7.65M
Total Liabilities	43.24M	36.88M	32.65M	21.97M
Total Debt	9.02M	10.9M	10.44M	8.26M
Common Stock	1.46B	1.44B	1.07B	783.17M
Retained Earnings	-899.47M	-665.14M	-482.75M	-357.37M
Comprehensive Income	-1.61M	-77K	-3M	-990K
Shareholders Equity	754.9M	927.92M	721.5M	550.03M
Total Investments	611.69M	782.23M	663.53M	376.09M